poisar

Stocks · News reference

Abercrombie & Fitch Posts Upbeat Q2 Results, Joins Semtech, Summit Therapeutics And Other Big Stocks Moving Higher On Wednesday

BenzingaAvi Kapoor

U.S. stocks mixed, Nasdaq up 0.1%. Abercrombie & Fitch shares surge 31.6% after beating earnings and raising forecasts. Other top gainers include Kanzhun, Capricor Therapeutics, Semtech Corp, and more.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchZacks.Com

    KANZHUN LIMITED Sponsored ADR (BZ) Earnings Expected to Grow: Should You Buy?

    KANZHUN LIMITED (BZ) is expected to report Q3 2026 earnings of $0.34 per share (+13.3% YoY) with revenues of $362.68 million (+19.4% YoY) on November 25. The stock has a positive Earnings ESP of +0.99% combined with a Zacks Rank #3 (Hold), suggesting it will likely beat consensus estimates. The company has beaten EPS estimates in 2 of the last 4 quarters.